Received: 24 April 2020
Accepted: 16 May 2020
First Online: 29 May 2020
Ethics approval and consent to participate
: Not applicable.
: All authors consent to the publication of the manuscript.
: GAR received lecture and consultation fees from Polichem S.A., Pierre Fabre, Vifor Pharma, Chiesi, Valeas; PP received speakers and consultations honoraria from AstraZeneca, Novartis, GSK, 4Life Pharma, ALK, Mundipharma; WF received speaker’s honoraria from Vifor Pharma, Sandoz, Ranbaxy, GSK. SB is employee of OM Pharma, a Vifor Pharma Company. AAC received lecture and consultation fees from Vifor Pharma.